Fused ring thrombin receptor antagonists

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S217000

Reexamination Certificate

active

08003803

ABSTRACT:
Fused-ring, heterocyclic-substituted tricyclics of the formulaor a pharmaceutically acceptable salt or solvate of said compound, isomer or racemic mixture wherein  represents an optional double bond, and wherein An, En, Mn, Gn, Jn, R3, n7, R8, R9, R10, R11, R32, R33, X, Y, B and Het are herein defined and the remaining substituents are as defined in the specification, are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds. Combination therapy with other cardiovascular agents is also claimed.

REFERENCES:
patent: 6063847 (2000-05-01), Chackalamannil et al.
patent: 6326380 (2001-12-01), Chackalamannil et al.
patent: 6645987 (2003-11-01), Chackalamannil et al.
patent: 7037920 (2006-05-01), Chackalamannil et al.
patent: 7713999 (2010-05-01), Chackalamannil et al.
patent: 2003/0203927 (2003-10-01), Chackalamannil et al.
patent: 2004/0152736 (2004-08-01), Chackalamannil et al.
patent: WO 94/03479 (1994-02-01), None
patent: WO 01/96330 (2001-12-01), None
Christine Espino & J. Du Bois, A Rh-Catalyzed C-H Insertion Reaction for the Oxidative Conversion of Carbamates to Oxazolidinones, 40 Angew. Chem. Intl. Ed.598 (2001).
Bensaid et al “The Cannabinoid CB, Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells”, Molecular Pharmacology, 63(4): 908-91.4 (2003).
Bernatowicz et al., “Development of Potent Thrombin Receptor Antagonist Peptides”,J. Med. Chem., 39: 4879-4887 (1996).
Chackalamannil, “A Highly Efficient Total Synthesis of (+)-Himbacine”,J. Am. Chem. Soc., 118: 9812-9813 (1996).
Pertwee, “Pharmacology of Cannabinoid Receptor Ligands”,Current Medicinal Chemistry, 6(8): 635-664 (1999).
PCT International Search Report dated Jan. 2, 2008 for PCT Application No. PCT/US2007/008978.
Chackalamannil, et al., Journal of Medicinal Chemistry, (2005), pp. 5884-5887, vol. 48, No. 19.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Fused ring thrombin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused ring thrombin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused ring thrombin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2618784

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.